Coreline Soft Signs Supply Agreement with Global Teleradiology Company to Target Multi-Billion Market in the U.S. and Europe

Coreline Soft announced on September 10, 2025 that it has signed a supply agreement with global teleradiology specialist Lungscreen to provide its proprietary artificial intelligence (AI) software, AVIEW LCS. Starting with this new partnership, the company plans to accelerate its entry into the global teleradiology market, including the U.S. and Europe.

Under the agreement, Coreline Soft’s revenue will scale in proportion to the number of cases using its AI-based lung disease diagnostic software. As Lungscreen not only conducts a large volume of CT (computed tomography) scans but is also expanding the number of CT studies performed, the company expects the deal to drive significant revenue growth.

Through this collaboration, Coreline Soft aims to broaden the application of AI to areas such as lung nodule follow-up management and COPD (chronic obstructive pulmonary disease), while strengthening its entry into the teleradiology market based on global partnerships. This follows a series of contracts with overseas players, including the U.K.-based DMC Healthcare last year and European remote diagnostics firm XCoorp GmbH earlier this year.

Lungscreen is currently participating in Australia’s newly launched National Lung Cancer Screening Program (NLSCP). The company has contracts with over 160 imaging centers across Australia and provides teleradiology services, interpreting more than 2,500 cases per month via its network. By combining Lungscreen’s extensive network with Coreline Soft’s AI software, the two companies intend to evolve beyond simple reading assistance into a comprehensive lung disease management platform.

“Lungscreen’s wide-ranging national screening network makes it a strategic partner for our overseas expansion,” said Jin-Kook Kim, CEO of Coreline Soft. “This agreement will accelerate our entry into national screening markets abroad by integrating Coreline’s AI technology with existing teleradiology infrastructures, while expanding our presence in the global teleradiology sector.”

Unlike in Korea, overseas teleradiology markets are rapidly growing, particularly in advanced economies such as the U.S. and Europe. According to market research firm Grand View Research, the global teleradiology market was valued at USD 15.6 billion (approximately KRW 22 trillion) last year and is projected to grow at an annual rate of more than 25% through 2030, driven by rising demand amid shortages of medical professionals.